Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia
- 1 December 1983
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 52 (10) , 1208-1213
- https://doi.org/10.1016/0002-9149(83)90575-1
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Clinical pharmacology of propafenone.Circulation, 1983
- Comparison of the electrophysiologic effects of intravenous and oral lorcainide in patients with recurrent ventricular tachycardia.Circulation, 1983
- Electrophysiology of oral encainideThe American Journal of Cardiology, 1982
- Electrophysiological and Antiarrhythmic Properties of Propafenon in Isolated Cardiac PreparationsJournal of Cardiovascular Pharmacology, 1981
- Electrophysiological effects of propafenone studied with programmed electrical stimulation of the heart in patients with recurrent paroxysmal supraventricular tachycardiaEuropean Heart Journal, 1981
- Effects of propafenone on TEA-induced action potentials in vascular smooth muscle of canine coronary arteriesCellular and Molecular Life Sciences, 1980
- Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.Circulation, 1978
- Significance of the Sinus-Node Recovery TimeCirculation, 1972
- Patterns of Atrioventricular Conduction in the Human HeartCirculation Research, 1970
- Localization of A-V conduction defects in man by recording of the his bundle electrogramThe American Journal of Cardiology, 1970